SM
CMD

Sciencast Management’s Cantel Medical Corporation CMD Stock Holding History

Sciencast Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,925
Closed -$376K – 653
2020
Q3 		$376K Buy
+7,925
New +$390K 0.14% 238
2020
Q1 		– Sell
-3,300
Closed -$219K – 626
2019
Q4 		$219K Buy
+3,300
New +$239K 0.06% 423

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Sciencast Management's CMD Position: Q4 2020 in Review

Sciencast Management sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 7,925 shares — an estimated $376K sold.

Sciencast Management first reported a position in CMD in Q4 2019 and held it in 2 quarters. The position peaked at $376K in Q3 2020. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Sciencast Management reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Sciencast Management sold 7,925 Cantel Medical Corporation shares in Q4 2020, an estimated $376K.
  • Sciencast Management first reported a position in Cantel Medical Corporation in Q4 2019 and held it in 2 quarters.
  • Sciencast Management's Cantel Medical Corporation position peaked at $376K in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Sciencast Management's 13F filing for Q4 2020, filed 4 Feb 2021.